EU Marketing Setback For Ipsen’s Connective Tissue Disease Drug

 
• By Neena Brizmohun
  
The EMA said the benefits of Sohonos did not outweigh its risks • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography